Three dimensional pharmacophore modelling of monoamine oxidase-A (MAO-A) inhibitors

5Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Flavoprotein monoamine oxidase is located on the outer membrane of mitochondria. It catalyzes oxidative deamination of monoamine neurotransmitters such as serotonin, norepinephrine and dopamine and hence is a target enzyme for antidepressant drugs. MAO (mono amine oxidase) has two isoforms, namely MAO-A and MAO-B. MAO-A isoform has higher affinity for serotonin and norepinephrine, while; MAO-B preferentially deaminates phenylethylamine and benzylamine. These important properties determine the clinical importance of MAO inhibitors. Selective MAO-A inhibitors are used in the treatment of neurological disorders such as depression. In this article we have developed a Hypogen pharmacophore for a set of 64 coumarin analogs and tried to analyze the intermolecular H-bonds with receptor structure. © 2007 by MDPI.

Author supplied keywords

Cite

CITATION STYLE

APA

Sairam, K. V. V. M., Khar, R. K., Mukherjee, R., & Jain, S. K. (2007). Three dimensional pharmacophore modelling of monoamine oxidase-A (MAO-A) inhibitors. International Journal of Molecular Sciences, 8(9), 894–919. https://doi.org/10.3390/i8090894

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free